The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation

Introduction <br> HIV is a highly diverse virus with significant genetic variability which may confer biologic differences that could impact on treatment outcomes. <br> Materials and methods <br> We studied the association between HIV subtypes and immunologic and virologic outcome...

Detaylı Bibliyografya
Asıl Yazarlar:	Ogbenna, AA, Meloni, S, Inzaule, S, Hamers, RL, Sigaloff, K, Osibogun, A, Adeyemo, TA, Okonkwo, P, Samuels, JO, Kanki, PJ, Rinke de Wit, TF, Akanmu, AS
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Public Library of Science 2019

Benzer Materyaller

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation.
Yazar:: Ann Abiola Ogbenna, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa
Yazar:: Inzaule, SC, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children
Yazar:: Inzaule, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens
Yazar:: Inzaule, SC, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Does tenofovir-containing first-line antiretroviral therapy mitigate the impact of pretreatment non-nucleoside reverse transcriptase inhibitor drug resistance?
Yazar:: Inzaule, SC, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa
Yazar:: Inzaule, SC, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa
Yazar:: Boender, T, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Iron stores in regular blood donors in Lagos, Nigeria
Yazar:: Adediran A, ve diğerleri
Baskı/Yayın Bilgisi: (2013-06-01)

Pan-resistant HIV-1: what's next?
Yazar:: Hamers, RL, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study
Yazar:: Inzaule, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.
Yazar:: Giota Touloumi, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Is increasing pretreatment HIV drug resistance a real menace or minor detail?
Yazar:: Inzaule, SC, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

The evolving landscape of HIV drug resistance diagnostics for expanding testing in resource-limited settings
Yazar:: Inzaule, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
Yazar:: Inzaule, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Virological and Immunological Aspects of AIDS Pathogenesis
Yazar:: Brian Conway, ve diğerleri
Baskı/Yayın Bilgisi: (1994-01-01)

High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses
Yazar:: Sulaimon Akanmu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
Yazar:: Shivali S. Joshi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-02-01)

Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk
Yazar:: Inzaule, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
Yazar:: Seth C Inzaule, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
Yazar:: Seth C Inzaule, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa
Yazar:: Boender, T, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

High levels of pre‐treatment HIV drug resistance and treatment failure in Nigerian children
Yazar:: Ragna S Boerma, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Pattern of von Willebrand factor in hypertensive patients in Lagos, Nigeria
Yazar:: Ann Abiola Ogbenna, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Derangement of protein S and C4b-binding protein levels as acquired thrombophilia in HIV-infected adult Nigerians
Yazar:: Fatai O. Bello, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia.
Yazar:: Kaye, S, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Immunological and virological triggers of type 1 diabetes: insights and implications
Yazar:: Joana R. N. Lemos, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Virologic and immunologic status of children with HIV-TB co-infections
Yazar:: Djatnika Setiabudi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
Yazar:: Seth C. Inzaule, ve diğerleri
Baskı/Yayın Bilgisi: (2018-10-01)

Adoption is not associated with immunological and virological outcomes in children with perinatally acquired HIV infection in the Netherlands.
Yazar:: Malon Van Den Hof, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Prevalence of cardiovascular risk factors amongst traders in an urban market in Lagos, Nigeria
Yazar:: T O Odugbemi, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse.
Yazar:: Vasiliver-Shamis, G, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
Yazar:: Touloumi, G, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

The immunological and virological consequences of planned treatment interruptions in children with HIV infection
Yazar:: Klein, N, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Flow cytometry and immunohistochemistry of the mouse dural meninges for immunological and virological assessments
Yazar:: Annie Roussel-Queval, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse
Yazar:: Gaia Vasiliver-Shamis, ve diğerleri
Baskı/Yayın Bilgisi: (2010-05-01)

Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection
Yazar:: Jintanat Ananworanich, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
Yazar:: Esther O Oluwole, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Pan-resistant HIV-1: what's next?
Yazar:: Raph L Hamers, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.
Yazar:: Bastian Neesgaard, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

‘HIV & TB Drug Resistance & Clinical Management Case Book’ by T Rossouw, R J Lessells, T de Oliveira. Cape Town: South African Medical Research Council, 2013. ISBN 978-1-920014-91-9.
Yazar:: K E Sigaloff, ve diğerleri
Baskı/Yayın Bilgisi: (2013-06-01)